BMJ 1994;309:126 (9 July)

Letters

Patients are unwilling to enter randomised trials

EDITOR,--The Medical Research Council is carrying out a trial comparing chemotherapy and surgery versus surgery alone in oesophageal carcinoma. Of the last six patients with oesophageal cancer with whom I have discussed this trial, only one has agreed to be randomised. The remaining five declined because they were not willing to risk a possible delay of six to eight weeks to their surgery should they have been randomised to the chemotherapy arm or because of disquiet over the possible side effects of chemotherapy during a period of natural anxiety before they underwent major surgery.

These genuine anxieties may well account for some of the poor rates of accrual to trials of treatment of oesophageal cancer.1

T C B Dehn 

Consultant surgeon Royal Berkshire Hospital, Reading RG1 5AN.


1 O'Reily S, Forastiere A. New approaches to treating oesophageal cancer. BMJ 1994;308:1249-50. (14 May.)
    [Full Text]

Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to StumbleUpon StumbleUpon   Add to Technorati Technorati    What's this?

Relevant Articles

Patients are unwilling to enter clinical trials
F Macbeth
BMJ 1994 309: 539-540. [Extract] [Full Text]

New approaches to treating oesophageal cancer
S O'Reilly and A Forastiere
BMJ 1994 308: 1249-1250. [Extract] [Full Text]

This article has been cited by other articles:

  • Fielding, L P., Grace, R., Hittinger, R. (1995). Limitations of randomised controlled trials. BMJ 310: 1410-1410 [Full text]  
  • Macbeth, F (1994). Patients are unwilling to enter clinical trials. BMJ 309: 539b-540 [Full text]  



Access jobs at BMJ Careers
Whats new online at Student 

BMJ